Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

19 pages, Nov 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Positive growth expected in cough, cold and allergy (hay fever) remedies

Over the forecast period, cough, cold and allergy (hay fever) remedies is expected to register a value CAGR of 2% at constant 2017 prices and this is set to be a major improvement on the marginally positive value CAGR recorded in the category constant 2017 terms over the review period. The acceleration in the category’s performance is set to be due to the changing climate and changing lifestyles among the Dutch population.

Climate change set to influence sales

As sales of cough, cold and allergy (hay fever) remedies remain highly dependent on the prevailing weather and climatic conditions, it is expected that climate change will boost demand in the category, especially towards the end of the forecast period. Specifically, consumer trends in the category are expected to evolve towards the use of several products in different formats and the use of combination products is likely to increase over the course of the forecast period as greater numbers of consumers seek to relieve the symptoms of colds, flu and allergies.

Competition likely to come from herbal/traditional remedies

One major potential threat to growth in cough, cold and allergy (hay fever) remedies over the forecast period is likely to be the growing interest in natural remedies among the Dutch population. The coming years are expected to see increasing numbers of consumers switching to herbal/traditional products as part of the general shift towards healthier lifestyles as distrust in standard OTC medicines continues to build.

COMPETITIVE LANDSCAPE

Leading players remain largely unchanged

2017 saw Lofthouse of Fleetwood, GSK Consumer Healthcare and Richardson-Vicks remain the leading companies within cough, cold and allergy (hay fever) remedies. Combined, these three companies accounted for 34% of value sales in the category during the year.

Innovation continues to define the category

The leading manufacturers of cough, cold and allergy (hay fever) remedies are constantly taking steps to improve the efficacy of OTC cough, cold and allergy remedies in an effort to target different types of symptoms. The leading OTC brands regularly launch products which can address different types of ailments and which are targeted towards the needs of consumers.

Private label remains a small but dynamic and influential player

Private label accounted for 15% of value sales in cough, cold and allergy (hay fever) remedies in 2017, with nasal sprays and nasal decongestant drops the categories in which it generated its highest value shares. Private label registered value share growth in every category of cough, cold and allergy (hay fever) remedies over the review period and further success is expected for private label over the forecast period.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands?
What are the major brands in Netherlands?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Positive growth expected in cough, cold and allergy (hay fever) remedies

Climate change set to influence sales

Competition likely to come from herbal/traditional remedies

COMPETITIVE LANDSCAPE

Leading players remain largely unchanged

Innovation continues to define the category

Private label remains a small but dynamic and influential player

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 3 Sales of Decongestants by Category: Value 2012-2017
Table 4 Sales of Decongestants by Category: % Value Growth 2012-2017
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Positive value growth remains a constant for consumer health

Weather conditions continue to influence sales trends in consumer health

Multinational companies remain dominant as smaller players gain ground

Changing shopping habits spur the evolution of the retail environment

Consistently positive value growth expected over the forecast period

MARKET INDICATORS

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 10 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 11 Sales of Consumer Health by Category: Value 2012-2017
Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Positive growth expected in cough, cold and allergy (hay fever) remedies

Climate change set to influence sales

Competition likely to come from herbal/traditional remedies

COMPETITIVE LANDSCAPE

Leading players remain largely unchanged

Innovation continues to define the category

Private label remains a small but dynamic and influential player

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands - Category analysis

HEADLINES

PROSPECTS

Positive growth expected in cough, cold and allergy (hay fever) remedies

Climate change set to influence sales

Competition likely to come from herbal/traditional remedies

COMPETITIVE LANDSCAPE

Leading players remain largely unchanged

Innovation continues to define the category

Private label remains a small but dynamic and influential player

CATEGORY DATA

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

Positive value growth remains a constant for consumer health

Weather conditions continue to influence sales trends in consumer health

Multinational companies remain dominant as smaller players gain ground

Changing shopping habits spur the evolution of the retail environment

Consistently positive value growth expected over the forecast period

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports